SEVERANCE AND RELEASE AGREEMENTSeverance and Release Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Severance and Release Agreement (the “Agreement”) is made by and between Bellerophon Therapeutics, Inc. (the “Company”) and Manesh Naidu (the “Employee”) (collectively, the “Parties”).
FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENTTransition Services Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is entered into the later of the dates in the signature block below (the “Amendment Effective Date”) by and between Ikaria, Inc., a Delaware corporation having a place of business at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 (“Ikaria”), and Bellerophon Therapeutics LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Suite 301, Hampton, NJ 08827 (“Bellerophon”). Ikaria and Bellerophon may be individually referred to as a “Party” and together as the “Parties.”
FIRST AMENDMENT TO SERVICES AGREEMENTServices Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO SERVICES AGREEMENT (this “Amendment”) is entered into the later of the dates in the signature block below (the “Amendment Effective Date”) by and between Ikaria, Inc., a Delaware corporation having a place of business at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 (“Ikaria”), and Bellerophon Therapeutics LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Suite 301, Hampton, NJ 08827 (“Bellerophon”). Ikaria and Bellerophon may be individually referred to as a “Party” and together as the “Parties.”
LEASE AGREEMENT BETWEEN 184 PROPERTY OWNER, LLC, a New Jersey limited liability company, LANDLORD, -AND- BELLEROPHON THERAPEUTICS, INC. a Delaware corporation, TENANT DATED: August 6, 2015Lease Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This LEASE AGREEMENT (this “Lease”) is dated August 6, 2015 and is between 184 PROPERTY OWNER, LLC, a New Jersey limited liability company (“Landlord”), and BELLEROPHON THERAPEUTICS, INC. a Delaware corporation (“Tenant”).
Exhibit A Form of Amendment to Non-Compete Agreements AMENDMENT TO AGREEMENT NOT TO COMPETEBellerophon Therapeutics, Inc. • November 12th, 2015 • Pharmaceutical preparations
THIS AMENDMENT TO AGREEMENT NOT TO COMPETE (this “Amendment”) is entered into the later of the dates in the signature block below (the “Amendment Effective Date”) by and between Ikaria Acquisition LLC (f/k/a Ikaria Acquisition, Inc.), a Delaware limited liability company having a place of business at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 (“Ikaria”), and [Bellerophon ], a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Suite 301, Hampton, NJ 08827 (“Bellerophon”). Ikaria and Bellerophon may be individually referred to as a “Party” and together as the “Parties.”
PROFESSIONAL SERVICES AGREEMENTProfessional Services Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
THIS PROFESSIONAL SERVICES AGREEMENT (this “Agreement”) is made the later of the dates in the signature block below (the “Effective Date”), by and between Bellerophon Services, Inc., a Delaware corporation having an office at 184 Liberty Corner Road, Suite 302, Warren, NJ 07059 (“Company”), and the party indicated below (“Consultant”).
SECOND AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENTMatters Agreement • November 12th, 2015 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO EXCLUSIVE CROSS-LICENSE, TECHNOLOGY TRANSFER, AND REGULATORY MATTERS AGREEMENT (this “Amendment”) is entered into the later of the dates in the signature block below (the “Amendment Effective Date”) by and between INO Therapeutics LLC, a Delaware limited liability company having a place of business at Perryville III Corporate Park, 53 Frontage Road, Third Floor, Hampton, NJ 08827 (“Ikaria”), and Bellerophon Pulse Technologies LLC, a Delaware limited liability company, with offices at Perryville III Corporate Park, 53 Frontage Road, Suite 301, Hampton, NJ 08827 (“Pulse Technologies”). All capitalized terms not defined herein shall have the same meanings ascribed thereto in the Exclusive Cross-License, Technology Transfer, and Regulatory Matters Agreement dated as of February 9, 2014 by and between Ikaria and Pulse Technologies (as amended on March 27, 2014, the “Agreement”). Ikaria and Pulse Technologies may be individually referred to as a “Party” and together
